... cells that dramatically alter their fate," said Deepak Srivastava, Director of Cardiovascular and Stem Cell Research, Gladstone Institutes. "We are thrilled to be part of the Fluidigm C1 Single-Cell Auto Prep System's Early Access Program and look ...
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130102005229&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130102005229&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment